Non-motor symptom burden in patients with Parkinson's disease with impulse control disorders and compulsive behaviours : results from the COPPADIS cohort

The study was aimed at analysing the frequency of impulse control disorders (ICDs) and compulsive behaviours (CBs) in patients with Parkinson's disease (PD) and in control subjects (CS) as well as the relationship between ICDs/CBs and motor, nonmotor features and dopaminergic treatment in PD patients. Data came from COPPADIS-2015, an observational, descriptive, nationwide (Spain) study. We used the validated Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) for ICD/CB screening. The association between demographic data and ICDs/CBs was analyzed in both groups. In PD, this relationship was evaluated using clinical features and treatment-related data. As result, 613 PD patients (mean age 62.47 ± 9.09 years, 59.87% men) and 179 CS (mean age 60.84 ± 8.33 years, 47.48% men) were included. ICDs and CBs were more frequent in PD (ICDs 12.7% vs. 1.6%, p < 0.001; CBs 7.18% vs. 1.67%, p = 0.01). PD patients had more frequent previous ICDs history, premorbid impulsive personality and antidepressant treatment (p < 0.05) compared with CS. In PD, patients with ICDs/CBs presented younger age at disease onset, more frequent history of previous ICDs and premorbid personality (p < 0.05), as well as higher comorbidity with nonmotor symptoms, including depression and poor quality of life. Treatment with dopamine agonists increased the risk of ICDs/CBs, being dose dependent (p < 0.05). As conclusions, ICDs and CBs were more frequent in patients with PD than in CS. More nonmotor symptoms were present in patients with PD who had ICDs/CBs compared with those without. Dopamine agonists have a prominent effect on ICDs/CBs, which could be influenced by dose

Azole assisted C-H bond activation promoted by an osmium-polyhydride: Discerning between N and NH

This is an open access article published under a Creative Commons Attribution (CC-BY) License.The capacity of the hexahydride complex OsH6(PiPr3)2 (1) to discern between the nitrogen atom and the NH unit in the azole assisted aryl C−H bond activation has been investigated. Complex 1 reacts with 2-phenylimidazole to give OsH3{κ2-C,N-(C6H4-imidazole)}(PiPr3)2 (2), which has been characterized by X-ray diffraction analysis. The structure proves the higher affinity of the metal center for the N atom in the presence of the NH unit, which remains unchanged, and reveals that in the solid state the molecules of this complex form infinite chains by means of intermolecular asymmetric 3-center bifurcated dihydrogen bonds. In solution, 1HDOSY NMR experiments suggest that the association degree decreases as the temperature increases. The fused six-membered ring of benzimidazole weakens the NH bond, enhancing its reactivity. As a consequence, complex 1 cannot discern between the N atom and the NH unit of 2-phenylbenzimidazole. Thus, the treatment of 1 with this substrate leads to a mixture of OsH3{κ2-C,N-(C6H4-benzimidazole)}(PiPr3)2 (3) and the dinuclear species (PiPr3)2H3Os(C6H4-benzimidazolate)OsH(η2-H2)(PiPr3)2 (4). The latter is the result of a N-assisted ortho-C−H bond activation of the phenyl group promoted by 0.5 equiv of 1 and the N−H bond activation promoted by the remaining 0.5 equiv of hexahydride 1 along with the agostic coordination of the remaining ortho-C−H bond to the metal center of the unsaturated fragment OsH(η 2-H2)(PiPr3)2. The comparison of the redox properties of 3 and 4 suggests that the interaction between the metal centers in the dinuclear compound is negligible. The replacement of the NH group of the azoles by a sulfur atom does not modify the behavior of the substrates. Thus, the reactions of 1 with 2-phenylthiazole and 2-phenylbenzothiazole afford OsH3{κ 2-C,N-(C6H4-thiazole)}(PiPr3)2 (5) and OsH3{κ2-C,N-(C6H4-benzothiazole)}(PiPr3)2 (6). In turn, complexes 2, 3, 5, and 6 are phosphorescent.Financial support from the Spanish MINECO and FEDER (Projects CTQ2013-46459-C2-01-P to M.A.S., CTQ2014-52799-P to M.A.E., CTQ2013-44303-P to I.F., CTQ2014-54071-P to A.L., and CTQ2014-51912-REDC, the DGA (E35), and the European Social Fund (FSE) is acknowledged.Peer Reviewe